BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2598466)

  • 1. Immunoreactive anionic and cationic trypsin in human serum.
    Kimland M; Russick C; Marks WH; Borgström A
    Clin Chim Acta; 1989 Sep; 184(1):31-46. PubMed ID: 2598466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis.
    Petersson U; Appelros S; Borgström A
    Int J Pancreatol; 1999 Jun; 25(3):165-70. PubMed ID: 10453418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.
    Borgström A; Andrén-Sandberg A
    Int J Pancreatol; 1995 Dec; 18(3):221-5. PubMed ID: 8708393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
    Borgström A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immunoreactive trypsin as a means of differentiating graft pancreatitis and allograft rejection after porcine pancreatic transplantation.
    Källén R; Borgström A
    Transplantation; 1992 Jan; 53(1):25-9. PubMed ID: 1733080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
    Geokas MC; Largman C; Brodrick JW; Johnson JH
    Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
    Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
    Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis.
    Itkonen O; Koivunen E; Hurme M; Alfthan H; Schröder T; Stenman UH
    J Lab Clin Med; 1990 Jun; 115(6):712-8. PubMed ID: 2366031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for determination of immunoreactive trypsin in complex with alpha 1-antitrypsin in human sera.
    Borgström A; Ohlsson K
    Scand J Clin Lab Invest; 1984 Sep; 44(5):381-6. PubMed ID: 6333064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolation and partial characterization of trypsinogen, pancreatic secretory trypsin inhibitor and multiple forms of chymotrypsinogen and trypsin from the pancreas of the ostrich (Struthio camelus).
    Smith N; Naudé RJ; Oelofsen W; Lazure C; Patthy A
    Int J Biochem; 1992 Jun; 24(6):877-85. PubMed ID: 1612178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
    Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
    Rinderknecht H; Renner IG; Abramson SB; Carmack C
    Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas.
    Rinderknecht H; Renner IG; Carmack C
    Gut; 1979 Oct; 20(10):886-91. PubMed ID: 533700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and N-terminal amino acid sequence determination of anionic and cationic canine trypsinogens.
    Borgström A
    Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):657-61. PubMed ID: 468111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences.
    Guy O; Lombardo D; Bartelt DC; Amic J; Figarella C
    Biochemistry; 1978 May; 17(9):1669-75. PubMed ID: 656395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and partial characterization of feline trypsin.
    Steiner JM; Medinger TL; Williams DA
    Comp Biochem Physiol B Biochem Mol Biol; 1997 Jan; 116(1):87-93. PubMed ID: 9080665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between serum trypsinogen-2 and pancreatic cancer.
    Cao J; Xia C; Cui T; Guo H; Li H; Ren Y; Wang S
    Hepatogastroenterology; 2015; 62(138):435-40. PubMed ID: 25916077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anionic and cationic dog trypsin. Isolation and partial characterization.
    Ohlsson K; Tegner H
    Biochim Biophys Acta; 1973 Aug; 317(2):328-37. PubMed ID: 19999718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
    Berling R; Borgström A; Ohlsson K
    Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis.
    Borgström A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):677-81. PubMed ID: 669579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.